HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Herpes simplex virus type 1 entry is inhibited by the cobalt chelate complex CTC-96.

Abstract
The CTC series of cobalt chelates display in vitro and in vivo activity against herpes simplex virus types 1 and 2 (HSV-1 and HSV-2). The experiments described here identify the stage in the virus life cycle where CTC-96 acts and demonstrate that the drug inhibits infection of susceptible cells. CTC-96 at 50 microg/ml has no effect on adsorption of virions to Vero cell monolayers. Penetration assays reveal that CTC-96 inhibits entry of the virus independent of gC and cellular entry receptors. This observation was supported by the failure to detect the accumulation of virus-specified proteins and alpha mRNA transcripts when CTC-96 is present at the onset of infection. Moreover, virion-associated alphaTIF does not accumulate in the nucleus of cells infected in the presence of CTC-96. CTC-96 targets the initial fusion event between the virus and the cell and also inhibits cell-to-cell spread and syncytium formation. Furthermore, CTC-96 inhibits plaque formation by varicella-zoster virus and vesicular stomatitis virus as efficiently as by HSV-1. Collectively, these experiments suggest that CTC-96 is a broad-spectrum inhibitor of infection by enveloped viruses and that it inhibits HSV-1 infection at the point of membrane fusion independent of the type of virus and cellular receptors present.
AuthorsJ A Schwartz, E K Lium, S J Silverstein
JournalJournal of virology (J Virol) Vol. 75 Issue 9 Pg. 4117-28 (May 2001) ISSN: 0022-538X [Print] United States
PMID11287561 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't, Research Support, U.S. Gov't, P.H.S.)
Chemical References
  • Antiviral Agents
  • Herpes Simplex Virus Protein Vmw65
  • Organometallic Compounds
  • RNA, Messenger
  • Receptors, Virus
  • Viral Envelope Proteins
  • Viral Proteins
  • glycoprotein gC, herpes simplex virus type 1
  • CTC 96
  • Cobalt
Topics
  • Animals
  • Antiviral Agents (chemistry, pharmacology)
  • CHO Cells
  • Cell Nucleus (metabolism)
  • Chlorocebus aethiops
  • Cobalt (pharmacology)
  • Cricetinae
  • Herpes Simplex Virus Protein Vmw65 (metabolism)
  • Herpesvirus 1, Human (drug effects, metabolism, physiology)
  • Herpesvirus 3, Human (drug effects)
  • Humans
  • Molecular Structure
  • Organometallic Compounds (chemistry, pharmacology)
  • RNA, Messenger
  • Receptors, Virus (metabolism)
  • Vero Cells
  • Viral Envelope Proteins (metabolism)
  • Viral Proteins (metabolism)
  • Virus Replication (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: